HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of clinical and immunological features and mortality in common variable immunodeficiency and agammaglobulinemia patients.

Abstract
Common Variable Immunodeficiency (CVID) and agammaglobulinemia are two of the main types of symptomatic primary antibody deficiencies. The pathogenic origins of these two diseases are different; agammaglobulinemia is a group of inherited disorders that usually are caused by mutations in the gene encoding Bruton Tyrosine Kinase (BTK) protein while CVID is a heterogeneous disorder mainly without monogenic cause. However, both diseases share a characteristic of frequent bacterial infections, a decline in serum immunoglobulin levels, and abnormality in antibody responses. The demographics and immunologic parameters, clinical manifestation, and mortality statistics from 297 patients with CVID and agammaglobulinemia followed up over 2 decades in the Children's Medical Center of Iran. Age at onset of symptom in agammaglobulinemia was earlier than CVID but the course of disease in CVID patients was longer than agammaglobulinemia patients. Pulmonary infections were the most prevalent clinical manifestations in both groups of patients. Lymphadenopathy, hepatomegaly, and splenomegaly were significantly higher in CVID patients than agammaglobulinemia patients and there was a significant association between these complications and mortality in CVID patients. Among 297 patients, 128 patients (88 CVID and 40 agammaglobulinemia) deceased. The predominant causes of death in CVID patients were infections, chronic lung disease, and malignancy while in agammaglobulinemia patients were infections and respiratory failure. Infections, especially respiratory infections were the most common complication and cause of death in both CVID and agammaglobulinemia groups and recent treatment advances even Immunoglobulin replacement cannot completely control these complications. Thus prompt recognition and specific management of these complications are worthwhile.
AuthorsYasser Bagheri, Ahmad Vosughi, Gholamreza Azizi, Reza Yazdani, Fatemeh Kiaee, Nasim Hafezi, Shahriar Alimorad, Majid Khoshmirsafa, Farhad Seif, Gholamreza Hassanpour, Hassan Abolhassani, Asghar Aghamohammadi
JournalImmunology letters (Immunol Lett) Vol. 210 Pg. 55-62 (06 2019) ISSN: 1879-0542 [Electronic] Netherlands
PMID31059734 (Publication Type: Journal Article)
CopyrightCopyright © 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Biomarkers
  • Immunoglobulins
Topics
  • Adolescent
  • Adult
  • Agammaglobulinemia (diagnosis, immunology, mortality)
  • Biomarkers
  • Child
  • Common Variable Immunodeficiency (diagnosis, immunology, mortality)
  • Comorbidity
  • Disease Susceptibility
  • Female
  • Humans
  • Immunoglobulins (blood, immunology)
  • Lymphocyte Subsets (immunology, metabolism)
  • Male
  • Phenotype
  • Prognosis
  • Symptom Assessment
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: